Prospective Study On Adverse Drug Reactions: A Step Towards Patient Safety
Creators
- 1. Clinical Pharmacy department, A J Hospital and Research Centre, Mangalore
- 2. Director of Medical Administration, A J Hospital and Research Centre
Description
ABSTRACT
To identify the adverse drug reactions in the patients. To increase the reporting and awareness among the staffs. To evaluate the causality assessment and severity of ADRs. A prospective study was conducted for a period of one year from February 2019 to January 2020 in the Inpatients of AJ Hospital and Research Centre. Identified and reported ADRs were analyzed. ADR reporting questionnaire was provided to healthcare professionals to assess the knowledge about ADR. ADR causality assessment was carried out using WHO probability scale. Severity assessment of ADRs was done using modified Hartwig and Siegel severity scale. Paired t-test was applied to find the association between the two phases. A total of 100 ADRs were identified from 1120 patients.Causality assessment indicated that most of the ADRs were probably (85%) drug related. Severity of 79% reactions were reported as moderate. Study was categorized into two phases; Phase I and Phase II. Knowledge rate among respondents was found to be 67% in phase-I which had a remarkable increase in phase-II (92%). Common barrier for underreporting of ADR was lack of knowledge regarding ADR. The study concluded that interventions such as implementation of well-established reporting process and continuous training will help to reduce the current underreporting crisis.
Keywords: Adverse drug reactions, Causality assessment and severity, underreporting, interventions
Files
AJPTR121001.pdf
Files
(769.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:5480595c42551b679349034470415e37
|
769.6 kB | Preview Download |
Additional details
References
- Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK et al. Prevalence of Adverse drug reactions at a private tertiary care hospital in south in India. J Res Med Sci. 2011; 16(1):16-25.
- WHO- International drug monitoring the role of national centres. Tech Rep Ser WHO 1972, no 498. https://www.who-umc.org/media/2680/who-technical-report498.pdf. Last accessed on 10 Dec 2016
- Suke SG, Kosta P, Negi H. Role of pharmacovigilance in India: An overview. Online journal of public health informatics. 2015; 7(2).
- World Health Organization Uppsala Monitoring Centre (WHO-UMC) causality assessment system
- Priyadharsini R., Raja TAR2, Dhayaguruvasan M. A study on awareness of pharmacovigilance and determinants of underreporting of adverse drug reactions by health care professionals and general practitioners. Int J Basic Clin Pharmacol. 2017; 6(5):1227- 1232
- A.P. Gor, S.V. Desai. Adverse Drug Reactions (ADR) in the inpatients of Medicine Department of a Rural Tertiary Care Teaching Hospital and Influence of Pharmacovigilance in Reporting ADR. Indian J Pharmacol .2008; 40(1) : 37-40
- M. Shamna, C. Dilip, M. Ajmal. A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital. Saudi Pharmaceutical Journal. 2014; 22(4):303–308.
- Prasad Rv, Pasha MAM, Fatima A, Deepalatha C. A demographic study on gender related differences in adverse drug reactions of a tertiary care teaching hospital. Int J Community Med Public Health. 2017; 4(7):2344-2347
- Rayees N M, Sampath Kumar, Bharath Raj K C, Rajesh K S, Juno J Joel, Prasanna Shama K A. Prospective Observational Study on Adverse Drug Reactions in General Medicine Department of a Tertiary Care Teaching Hospital. RJPT.2019; 12(5): 2289-2298.
- . R Arulmani, S.D. Rajendran & B. Suresh. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol.2007; 65(2), 210–216.
- Stavreva G, Pendicheva, D, Pandurska. Detection of adverse drug reactions to antimicrobial drugs in hospitalized patients. Trakia J. Sci.2008; 6 (1), 7–9.
- Oshikoya, K.A, Njokanma, O.F, Chukwara. Adverse drug reactions in Nigerian children. Paediatr Perinat Drug Ther. 2007; 8(2): 881–88.
- Priyadharsini, R, Surendiran, A, Adithan, C. A study on adverse drug reactions in paediatric patients. J Pharmacol Pharmacother.2011; 2 (4), 277–280